Alexion Gets Second Priority Review Voucher With Approval Of Rare Enzyme Disorder Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Kanuma, the first approved treatment for lysosomal acid lipase deficiency, will launch in January at an average annual treatment cost of $310,000.